Corvite FEnone
Multivitamins (MVM)Brand: Vertical Pharmaceuticals
Net Contents
30 Pack
Serving Size
1 {Tablet(s)}
Servings Per Container
Not specified
Supplement Form
Tablet or Pill
Bar Code (UPC/SKU)
Not specified
Product Version
CFELB021101
Label Analysis
Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.
10 distinct active ingredients are disclosed in Supplement Facts.
Every active ingredient discloses a specific amount per serving.
This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.
Supplement Facts
Serving Size: 1 {Tablet(s)} · 1 per day
| Ingredient | Amount Per Serving | |
|---|---|---|
| Sumalate | 25 mg | — |
| Ferronyl Carbonyl Iron | 125 mg | — |
| Folate | 1 mg | — |
| Vitamin C(Calcium Ascorbate) | 160 mg | — |
| Calcium Threonate | 5 mg | — |
| Vitamin B6(Pyridoxine Hydrochloride) | 10 mg | — |
| Vitamin B12(Cyanocobalamin) | 15 mcg | — |
| Vitamin D3(Cholecalciferol) | 1000 IU | — |
| Zinc(TRAACS Zinc Glycinate Chelate) | 25 mg | — |
| Magnesium(Di-Magnesium Malate) | 15 mg | — |
Not Present
Other Ingredients
Target Groups
Label Claims
Directions & Suggested Use
Suggested/Recommended/Usage/Directions
DOSAGE AND ADMINISTRATION Usual adult dose is 1 tablet daily, or as prescribed by a physician.
Warnings & Precautions
Precautions re: All Other
WARNINGS Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Precautions re: All Other
Folic Acid Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.
Precautions re: All Other
ADVERSE REACTIONS Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.
Precautions re: Allergies
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Precautions re: All Other
OVERDOSAGE The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanossi, lassitude, seizures, shock and coma.
Precautions re: Children
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Precautions re: All Other
PRECAUTIONS General Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with CORVITE(R) FE. Since the anemia may be a result of a sytemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.
Precautions re: Children
Pediatric Use Safety and effectiveness in pediatric patients have not been established.
Precautions re: All Other
Geriatric Use Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious.
Precautions re: Children
KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.
Storage
Storage
STORAGE Store at controlled room temperature 15(0)-30(0)C (59(0)-86(0)F) [See USP]. Protect from light, moisture and excessive heat. Dispense in a tight, light resistant container as defined in the USP using a child-resistant closure.
Other Label Statements
General Statements: All Other Content
PRESCRIBING INFORMATION DESCRIPTION Red, oval bisected tablets embossed "VP042".
Brand IP Statement(s) re: (c), (TM), (SM)
HOW SUPPLIED CORVITE(R) FE available in carton unit dose pack of 30 (6 child resistant blister cards of 5 tablets per card).
Brand IP Statement(s) re: (c), (TM), (SM)
US Patent No. 5,516,925 US Patent No. 6,716,814 US Patent No. 7,838,042 US Patent No. 6,706,901 Other Patents Pending
General Statements: All Other Content
CLINICAL PHARMCOLOGY Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase. Vitamin B12 is required for the maintenance of normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of vitamin B12 from the gastrointestinal tract.
Brand IP Statement(s) re: (c), (TM), (SM)
INDICATIONS AND USAGE CORVITE(R) FE is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.
Brand IP Statement(s) re: (c), (TM), (SM)
CONTRAINDICATIONS CORVITE(R) FE is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.
General: Product/Version Code
CFELB021101
General Statements: All Other Content
Rx Only.
Brand IP Statement(s) re: (c), (TM), (SM)
DimaCal and TRAACS are registered trademarks of Albion Laboratories, Inc. Malates covered by U.S. Patent 6,706,904, chelate covered by U.S. Patent 7,838,042; and patents pending.
Brand IP Statement(s) re: (c), (TM), (SM)
Sumalate (ferrous asparto glycinate) is a trademark of Albion International, Inc., Clearfield, Utah.
Manufacturer & Distributor
Distributor
Vertical Pharmaceuticals, Inc.
Sayreville, NJ, 08872
Where to Buy Locally
Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.
Related News
Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2013-11-25. DSLD Label ID: 26580. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.
Related Products
1000 mg Vitamin C Acai Berry
Emergen-C
1000 mg Vitamin C Acai Berry
Emergen-C
1000 mg Vitamin C Chewables Orange Blast
Emergen-C
1000 mg Vitamin C Chewables Orange Blast
Emergen-C